Stocks360

Can B Corp. (CANB)

Stock analysis · OTC · Healthcare · Drug Manufacturers - Specialty & Generic

Share: Facebook X WhatsApp SMS
$0.02

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
$1.49M
PE (TTM)
-0.11
EPS (TTM)
N/A
Dividend Yield
0.00%
Beta
0.85
Day Range
$0.01 – $0.02
52-wk Range
$0.01 – $0.18
Avg Volume
N/A
Volume
658.95K

Can B Corp. (CANB) is a publicly traded company in the Healthcare sector. Latest price: $0.02. Market cap $1.49M. Trailing PE -0.11. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 5 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

Earnings

Most Recent
Nov 18, 2024
EPS $-0.05 vs est. $1.54
Missed by $1.59

Proprietary Signals

Signal snapshot temporarily unavailable.

About Can B Corp.

Can B Corp. operates within the United States, specializing in the development, manufacturing, and sale of products derived from cannabidiol (CBD). Its extensive range of hemp-based CBD offerings includes oils, topical creams, moisturizers, isolates, gel capsules, spa items, concentrates, and various lifestyle products. Customers can purchase these goods through the company's official website, automated vending machines, and via partnerships with medical professionals. The firm markets its products under distinct brand names such as Canbiola, Nu Wellness, Seven Chakras, and Pure Leaf Oil. The company, which changed its name from Canbiola Inc. to Can B Corp. in February 2020, was founded in 2005 and is headquartered in Hicksville, New York.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)-0.11×
P/S (TTM)0.00×
P/B-0.09×
P/FCF (TTM)-6.75×
EV / EBITDA-1.28×
EV / Sales0.00×
Earnings Yield-911.89%
Free Cash Flow Yield-14.83%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value$9.79M
Net Income (TTM)-$13.63M
Free Cash Flow (TTM)$1.56M
Net Debt$8.30M
Working Capital-$12.74M
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Return on Equity148.68%
Return on Invested Capital107.66%

Peers

Recent News

  • No recent news available.

Related

Browse more tickers: sitemap